Suchergebnisse - "Xu, Dongsheng"

PubPharm (7)

1

Promising targets based on pattern recognition receptors for cancer immunotherapy

enthalten in: Pharmacological research | 2020

von Bai, L. | Li, W. | Zheng, W. | +3

2

Docetaxel-decorated anticancer drug and gold nanoparticles encapsulated apatite carrier for the treatment of liver cancer

enthalten in: Journal of photochemistry and photobiology. B, Biology | 2018

von Wan, J. | Ma, X. | Xu, D. | +3

3

Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression

enthalten in: Frontiers in immunology | 2018

von Niu, C. | Li, M. | Zhu, S. | +7

4

Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma

enthalten in: Oncotarget | 2017

von Niu, C. | Jin, H. | Li, M. | +10

5

Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

enthalten in: Current topics in medicinal chemistry | 2016

von Xu, D. | Li, R. | Wu, J. | +2

6

Sodium orthovanadate inhibits growth of human hepatocellular carcinoma cells in vitro and in an orthotopic model in vivo

enthalten in: Cancer letters | 2014

von Wu, Y. | Ma, Y. | Xu, Z. | +10

7

Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo

enthalten in: Oncology reports | 2014

von Xu, D. | Ma, Y. | Zhao, B. | +9

1
[1]